Accelerating health workforce skills through a successful pilot program
Following a successful pilot run by RMIT University’s Health Transformation Lab and College of Vocational Education addressing digital skills shortages, the Victorian Government has increased its support with an additional $4.75 million announced to expand Skills Solutions Partnerships – a platform for training providers and industry to collaboratively develop programs addressing emerging skills needs across Victoria.
Gas-sensing capsule takes another big step from lab to commercialisation
An ingestible gas-sensing capsule that provides real-time insights into gut health has moved closer to market with RMIT University transferring IP ownership to medical device company Atmo Biosciences.
Scientists call for targeted fibre diets to boost health
Australian food scientists have reclassified dietary fibres – beyond just soluble and insoluble – to better guide nutritional decisions and drive targeted health food products.
Prosthetic leg donation program changes lives in Southeast Asia
A pioneering rehabilitation program has fitted more than 200 prosthetic legs and delivered 4,600 biomechanical therapy and counselling sessions in partnership with local programs across the region.
New study on drug checking: trend warnings and alerts
As more Australian jurisdictions begin drug checking trials at festivals and in the community, experts are exploring how the data could reach significantly more people.
Blood test could make cancer treatments safer and more effective
Scientists from RMIT University and the Doherty Institute have developed a new blood test that could screen cancer patients to help make their treatment safer and more effective.
Transforming construction health and safety with SHINe
RMIT has launched the Safety and Health Innovation Network (SHINe), an industry-led collaborative research funding model to identify and tackle problems across the construction industry.
Gold beats platinum for chemo drugs in new lab study
Gold-based drugs can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to new research out of RMIT University.